Subjective Cognitive Decline
56
12
18
24
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
1 terminated out of 56 trials
96.0%
+9.4% vs benchmark
0%
0 trials in Phase 3/4
4%
1 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 24 completed trials
Clinical Trials (56)
Early Diagnosis of SCD Based on Radiogenomics
LLM-Driven Daily Conversation for Cognitive Health in Older Adults
Internet-based Mind-Body Training for Brain Health
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression
Developing a Peer Support Intervention for Depression in SCD
The Brain Health Champion Study
Using Artificial Intelligence to Detect Early Signs of Alzheimer's Disease in People With Memory Concerns
Attentional Mechanisms in SCD
Cognitive Intervention With Go and Chess in Early and Subjective Cognitive Decline
Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients
Impact of a Cognitive Intervention Enriched With Leisure Activities in Persons With Subjective Cognitive Decline
Chinese Classics Recitation Training in Subjective Cognitive Decline
Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog
dTMS for Subjective Cognitive Decline
Effects of Mediterranean Diet on Subjective Cognitive Decline
Cholinergic Mechanisms of Attention in Aging
Gut-brain Health Effects of PREbiotics in Older Adults With Suspected COgnitive DEcline
Exergame-assisted Simultaneous Motor-cognitive Training for Middle-aged Old Adults in China
Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.